203519-37-3 Usage
General Description
ERT-BUTYL 4-(6-CHLORO-2-METHYL-4-PYRIMIDINYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is a chemical compound that falls under the category of pyrazinecarboxylate derivatives. It is also known as Ethyl 4-(6-chloro-2-methyl-4-pyrimidinyl)-1,4-diazepane-1-carboxylate. ERT-BUTYL 4-(6-CHLORO-2-METHYL-4-PYRIMIDINYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE may have potential applications in pharmaceuticals as it exhibits biological activity, particularly in the inhibition of certain enzymes. It is important to handle this chemical with caution and follow proper safety protocols to prevent any potential negative effects on health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 203519-37-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,5,1 and 9 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 203519-37:
(8*2)+(7*0)+(6*3)+(5*5)+(4*1)+(3*9)+(2*3)+(1*7)=103
103 % 10 = 3
So 203519-37-3 is a valid CAS Registry Number.
InChI:InChI=1/C14H21ClN4O2/c1-10-16-11(15)9-12(17-10)18-5-7-19(8-6-18)13(20)21-14(2,3)4/h9H,5-8H2,1-4H3
203519-37-3Relevant articles and documents
Compounds as syk kinase inhibitors
-
Paragraph 0144; 0145, (2013/03/26)
The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by inhibition of Syk kinase.
THIAZOLE INHIBITORS TARGETING RESISTANT AND KINASE MUTATIONS
-
Page/Page column 48-49, (2010/11/27)
A compound is provided, having the general structure (A): wherein A is an aryl or heteroaryl group, Y is a hydrophobic linking moiety, and L is a substitutent. The compound (A) can be used for treatment of various angiogenic-associated or hematologic disorders, such as myeloproliferative disorders in patients who do not respond to kinase-inhibition therapy that comprises administering currently used medications.
